Bachri H, Essangri H, El Bahaoui N, Benkabbou A, Mohsine R, Majbar AM, Souadka A. External validation of the Moroccan Arabic version of the European Organization for Research and Treatment of Cancer colorectal (CR29) module: Monocentric study. World J Methodol 2023; 13(4): 259-271 [PMID: 37771870 DOI: 10.5662/wjm.v13.i4.259]
Corresponding Author of This Article
Amine Souadka, MD, PhD, Professor, Surgical Oncology Department, National Institute of Oncology, Mohammed Vth University in Rabat, Hay riad Souissi, Rabat 10100, Morocco. a.souadka@um5r.ac.ma
Research Domain of This Article
Oncology
Article-Type of This Article
Observational Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Methodol. Sep 20, 2023; 13(4): 259-271 Published online Sep 20, 2023. doi: 10.5662/wjm.v13.i4.259
External validation of the Moroccan Arabic version of the European Organization for Research and Treatment of Cancer colorectal (CR29) module: Monocentric study
Houda Bachri, Hajar Essangri, Nezha El Bahaoui, Amine Benkabbou, Raouf Mohsine, Anass Mohammed Majbar, Amine Souadka
Houda Bachri, Hajar Essangri, Nezha El Bahaoui, Amine Benkabbou, Raouf Mohsine, Anass Mohammed Majbar, Amine Souadka, Surgical Oncology Department, National Institute of Oncology, Mohammed Vth University in Rabat, Rabat 10100, Morocco
Hajar Essangri, Gynecology oncology Department, Royal London Hospital, Barts NHS Health, London SE18 6EY, United Kingdom
Author contributions: Souadka A and Bachri H have contributed to the conception and design of the study, acquisition of the data, the analysis and the interpretation of data; Souadka A, Bachri H and Essangri H wrote the first draft; El Bahaoui N, Majbar AM and Benkabbou A critically reviewed the draft for important intellectual content; Mohsine R was involved in revising critically the corrected manuscript and all authors read and gave the final approval of the version to be published.
Institutional review board statement: The Approval of the study protocol was obtained from the institutional ethics review board (number: 79/17) and all patients enrolled in the study provided a written, informed consent allowing the use of their data for clinical studies at the time of their initial visit.
Conflict-of-interest statement: The authors declare no conflict of interest.
Data sharing statement: Derived data supporting the findings of this study are available from the corresponding author a.souadka@um5r.ac.ma upon reasonable request.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Amine Souadka, MD, PhD, Professor, Surgical Oncology Department, National Institute of Oncology, Mohammed Vth University in Rabat, Hay riad Souissi, Rabat 10100, Morocco. a.souadka@um5r.ac.ma
Received: April 22, 2023 Peer-review started: April 22, 2023 First decision: June 14, 2023 Revised: July 26, 2023 Accepted: September 1, 2023 Article in press: September 1, 2023 Published online: September 20, 2023
Abstract
BACKGROUND
Quality of life (QoL) outcomes are a focal endpoint of cancer treatment strategies.
AIM
To externally validate the Moroccan Arabic version of the European Organization for Research and Treatment of Cancer (EORTC) QoL Questionnaire (QLQ) for colorectal cancer (CRC) patients (CR29).
METHODS
Both Moroccan Arabic modules of QLQ-CR29 and QLQ-C30 were administered to Moroccan CRC. Psychometric properties were retested by measuring Cronbach’s alpha coefficient for reliability and Intraclass correlation coefficient (ICC) to examine test-retest reproducibility. The multitrait-scaling analysis was performed to demonstrate the validity of the instrument and known-groups comparison was used to test the score’s ability to discriminate between different groups of patients.
RESULTS
In total, 221 patients were included in our study and 34 patients completed the questionnaire twice. The Urinary Frequency scale and Stool Frequency scale had good internal consistency with alpha Cronbach coefficients of 0.79 and 0.83 respectively, while the same coefficients were moderately lower for the Blood and Mucus in Stool scale (0.61) and the Body Image scale (0.67). The ICCs ranged from 0.88 to 1 indicating good to excellent reproducibility. In multitrait scaling analyses, the criterion for item convergent and divergent validity was satisfactory. The known-group comparison showed statistically significant differences between patients according to age, gender, stoma status, tumor location, and radiotherapy.
CONCLUSION
The Moroccan Arabic version of the EORTC QLQ-CR29 is a valid and reliable tool that can be used safely for research and clinical purposes in Moroccan CRC patients.
Core Tip: Patient related outcomes such as quality of life (QoL) are a focal endpoint of cancer treatments strategies. Many QoL Questionnaire (QLQ) are not trully validated. We aim to externally validate the Moroccan Arabic version of the European Organization for Research and Treatment of Cancer QLQ CR29 on larger and more heterogenous population in order to affirm its validity and reliability in arabic colorectal cancer patients.
